Monoclonal Antibodies versus Histone Deacetylase Inhibitors in Combination with Bortezomib or Lenalidomide plus Dexamethasone for the Treatment of Relapsed or Refractory Multiple Myeloma: An Indirect-Comparison Meta-Analysis of Randomized Controlled Trials

Table 3

Quality assessment of included studies according to Jadad scale.

Study	Randomization	Blinding	Withdrawal or lost to follow-up	Total Jadad score
Palumbo et al. (2016)	2	0	1	3
Dimopoulos et al. (2016)	2	0	1	3
Lonial et al. (2015)	2	0	1	3
Jakubowiak et al. (2016)	2	0	1	3
San-Miguel et al. (2014)	2	2	1	5
Dimopoulos et al. (2013)	2	2	1	5